US Stock MarketDetailed Quotes

OFIX Orthofix Medical

  • 14.620
  • -0.270-1.81%
Close May 28 16:00 ET
548.68MMarket Cap-4351P/E (TTM)

About Orthofix Medical Company

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

Company Profile

Company NameOrthofix Medical
Listing DateApr 23, 1992
Issue Price12.00
CEOMr. Massimo Calafiore
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3451 Plano Parkway
CountryUnited States of America
Zip Code75056

Company Executives

  • Name
  • Position
  • Salary
  • Massimo Calafiore
  • President and Chief Executive Officer
  • --
  • Puja Leekha
  • Interim Chief Legal Officer, Senior Vice President, Chief Ethics and Compliance Officer
  • --
  • Julie B. Andrews
  • Chief Financial Officer
  • --
  • Geoffrey C. Gillespie
  • Vice President and Corporate Controller
  • --
  • Catherine M. Burzik
  • Chairman of the Board
  • 388.85K
  • Kimberley A. Elting
  • President, Global Orthopedics
  • 2.97M
  • Stuart M. Essig, PhD
  • Independent Director
  • --
  • James F. Hinrichs
  • Independent Director
  • 266.41K
  • Shweta Singh Maniar
  • Independent Director
  • --
  • Michael E. Paolucci
  • Independent Director
  • 261.41K
  • John B. Henneman, III
  • Independent Director
  • --
  • Charles R. Kummeth
  • Independent Director
  • --
  • Alan L. Bazaar
  • Independent Director
  • --
  • Wayne C. Burris
  • Independent Director
  • 251.41K
  • Michael M. Finegan
  • Independent Director
  • --
  • Jason M. Hannon
  • Independent Director
  • 261.41K


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price